Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171908 | SCV000055161 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Blueprint Genetics | RCV000171908 | SCV000928030 | uncertain significance | not provided | 2018-10-31 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170911 | SCV001333549 | uncertain significance | Cardiomyopathy | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002517657 | SCV003452250 | likely benign | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8 | 2024-08-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995664 | SCV004823926 | uncertain significance | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma | 2023-02-24 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with glutamine at codon 129 of the DSP protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with DSP-related disorders in the literature. This variant has been identified in 3/251396 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV000171908 | SCV005188786 | uncertain significance | not provided | criteria provided, single submitter | not provided |